These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20671857)

  • 21. Effectiveness of Robotic Exoskeleton-Assisted Gait Training in Spinocerebellar Ataxia: A Case Report.
    Kim SH; Han JY; Song MK; Choi IS; Park HK
    Sensors (Basel); 2021 Jul; 21(14):. PubMed ID: 34300613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A sporadic case of spinocerebellar ataxia 6 (SCA 6) with large CAG expansion of the CACNL1A4 gene].
    Izumi Y; Sawada H; Matsuyama Z; Kawakami H; Udaka F; Nakamura S; Kameyama M
    No To Shinkei; 1999 Feb; 51(2):167-70. PubMed ID: 10198907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressive and memory symptoms as presenting features of spinocerebellar ataxia.
    McMurtray AM; Clark DG; Flood MK; Perlman S; Mendez MF
    J Neuropsychiatry Clin Neurosci; 2006; 18(3):420-2. PubMed ID: 16963595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinocerebellar ataxia type 8 in Scotland: genetic and clinical features in seven unrelated cases and a review of published reports.
    Zeman A; Stone J; Porteous M; Burns E; Barron L; Warner J
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):459-65. PubMed ID: 14966165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial.
    Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA
    J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Antidepressant Treatment on Peripheral Biomarkers in Patients with Major Depressive Disorder (MDD).
    Mosiołek A; Pięta A; Jakima S; Zborowska N; Mosiołek J; Szulc A
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-motor symptoms in patients with autosomal dominant spinocerebellar ataxia.
    Mastammanavar VS; Kamble N; Yadav R; M N; Jain S; Kumar K; Pal PK
    Acta Neurol Scand; 2020 Oct; 142(4):368-376. PubMed ID: 32677041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacoeconomic evaluation of major depressive disorder (Italy).
    Casciano J; Arikian S; Tarride JE; Doyle JJ; Casciano R
    Epidemiol Psichiatr Soc; 1999; 8(3):220-31. PubMed ID: 10638040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
    Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
    Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spinocerebellar ataxia type 8 in Scotland: frequency, neurological, neuropsychological and neuropsychiatric findings.
    Torrens L; Burns E; Stone J; Graham C; Wright H; Summers D; Sellar R; Porteous M; Warner J; Zeman A
    Acta Neurol Scand; 2008 Jan; 117(1):41-8. PubMed ID: 18095954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment patterns in patients with treatment-resistant depression in Danish patients with major depressive disorder.
    Gronemann FH; Petersen J; Alulis S; Jensen KJ; Riise J; Ankarfeldt MZ; Solem EJ; Bødker N; Osler M
    J Affect Disord; 2021 May; 287():204-213. PubMed ID: 33799039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion body myositis in patients with spinocerebellar ataxia types 3 and 6.
    Rietveld A; van Gaalen J; Saris C; Okkersen K; Küsters B; van de Warrenburg B; van Engelen B; Sacconi S; Raaphorst J
    J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):876-878. PubMed ID: 32576615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential role of monocyte chemoattractant protein-1 for major depressive disorder.
    Pae CU
    Psychiatry Investig; 2014 Jul; 11(3):217-22. PubMed ID: 25110491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A trial of topiramate for patients with hereditary spinocerebellar ataxia.
    Miura S; Sawada R; Yorita A; Kida H; Kamada T; Yamanishi Y
    Clin Case Rep; 2023 Feb; 11(2):e6980. PubMed ID: 36855409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major depressive disorder (MDD), antidepressants, and uncontrolled hypertension: A report of intraoperative autonomic dysregulation.
    Paraskeva A; Theodosopoulou P
    Saudi J Anaesth; 2022; 16(4):481-484. PubMed ID: 36337405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two Complicated Nervous Cases, with Treatment.
    Vincent E
    Buffalo Med J; 1902 Mar; 41(8):586-587. PubMed ID: 36885548
    [No Abstract]   [Full Text] [Related]  

  • 38. Intensive Outpatient Treatment of Depression in a Spinocerebellar Ataxia Type 1 Patient.
    Black E
    Case Rep Psychiatry; 2019; 2019():9186797. PubMed ID: 30886755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autosomal dominant hereditary ataxia in Sri Lanka.
    Sumathipala DS; Abeysekera GS; Jayasekara RW; Tallaksen CM; Dissanayake VH
    BMC Neurol; 2013 May; 13():39. PubMed ID: 23634774
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.